Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
#Heart Defect Closure Device Market Value Growth And Long-Term Outlook#_x000D_
The market size for heart defect closure devices has seen substantial growth recently. This market is projected to expand from $1.27 billion in 2025 to $1.45 billion in 2026, at a compound annual growth rate (CAGR) of 14.5%. The historical growth can be ascribed to the increasing prevalence of congenital heart defects, developments in interventional cardiology, heightened awareness regarding septal defect treatments, the expansion of cardiac catheterization labs, and a rising demand for minimally invasive cardiac procedures._x000D_
_x000D_
The heart defect closure device market is poised for significant expansion in the coming years, with projections indicating it will reach $2.36 billion in 2030 at a compound annual growth rate (CAGR) of 12.9%. This anticipated growth during the forecast period is propelled by factors such as an expanding population of elderly and pediatric patients suffering from structural heart defects, an increasing adoption of transcatheter cardiac interventions, a rise in healthcare spending allocated to cardiovascular care, the proliferation of specialized cardiac centers, and an intensified focus on the early detection and management of heart defects. Furthermore, key market trends throughout the forecast period include the rising acceptance of minimally invasive transcatheter closure procedures, the growing utilization of nitinol-based and self-expanding closure devices, an increasing preference for device-based alternatives to open-heart surgery, the expansion of structural heart disease treatment programs, and an elevated emphasis on improving safety, efficacy, and long-term patient outcomes._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Heart Defect Closure Device Market Growth Momentum: What Factors Are Shaping Demand?#_x000D_
The future expansion of the heart defect closure device market is anticipated to be fueled by the increasing prevalence of individuals suffering from congenital heart conditions. These problems are defined as structural irregularities in the heart that exist from birth. The rise in congenital heart issues stems from genetic factors, environmental impacts, and maternal health complications like diabetes, obesity, contact with specific drugs, or infections during gestation. Heart defect closure devices aid in managing congenital heart issues through minimally invasive approaches that seal irregular heart openings, thereby re-establishing typical blood flow, lessening complications, and enhancing overall heart function. As an illustration, a report from August 2025 by the National Center for Biotechnology Information, a US governmental body, indicates a substantial projected increase in cardiovascular disease between 2025 and 2050. Prevalence is forecast to climb by 90.0%, crude mortality by 73.4%, and crude DALYs by 54.7%, resulting in an estimated 35.6 million cardiovascular fatalities in 2050, an increase from 20.5 million in 2025. Consequently, the expanding population affected by congenital heart problems is a key factor propelling the heart defect closure device market._x000D_
_x000D_
#Heart Defect Closure Device Market Segment Outlook: Which Categories Are Growing Fastest?#_x000D_
The heart defect closure device market covered in this report is segmented – _x000D_
_x000D_
1) By Type: Atrial Septal Defect (ASD) Closure Device, Left Atrial Appendage (LAA) Closure Devices, Patent Foramen Ovale (PFO) Closure Devices, Patent Ductus Arteriosus (PDA) Closure Devices, Ventricular Septal Defect (VSD) Closure Devices_x000D_
2) By Material: Nitinol-Based Devices, Stainless Steel Devices, Other Materials_x000D_
3) By Mode Of Delivery: Transcatheter Delivery, Surgical Delivery, Other Modes_x000D_
4) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Users_x000D_
_x000D_
Subsegments:_x000D_
1) By Atrial Septal Defect (ASD) Closure Device: Occluder Devices (Septal Occluders), Implantable Patch Devices, Self-Expanding Devices, Balloon-Expandable Devices _x000D_
2) By Left Atrial Appendage (LAA) Closure Devices: Occluder Devices (WATCHMAN Device), Clip-Based Devices, Self-Expanding LAA Closure Devices _x000D_
3) By Patent Foramen Ovale (PFO) Closure Devices: Septal Occluders, Self-Expanding Occluders, Balloon-Expandable Occluders _x000D_
4) By Patent Ductus Arteriosus (PDA) Closure Devices: Coil-Based Closure Devices, Stent-Based Closure Devices, Amplatzer Occluders _x000D_
5) By Ventricular Septal Defect (VSD) Closure Devices: Septal Occluder Devices, Balloon-Expandable Occluders, Self-Expanding Occluders_x000D_
_x000D_
#Heart Defect Closure Device Market Trends Redefining Industry Growth#_x000D_
Leading companies in the heart defect closure device market are progressing technologies such as device tracking tools, aiming to boost procedural exactness and elevate clinician confidence. A device tracking tool is a system offering real-time visualization of medical device position and movement during treatment. For instance, in November 2025, Philips, a Netherlands-based health technology company, unveiled DeviceGuide—an AI-driven tracking solution. This innovation is designed to assist clinicians during intricate minimally invasive heart valve repair procedures, particularly for mitral valve regurgitation. Operating in conjunction with the EchoNavigator platform, DeviceGuide merges live X-ray and ultrasound imaging to generate a real-time 3D model of the repair device within the beating heart, thereby enhancing visual clarity, spatial understanding, and overall precision. Developed through a partnership with Edwards Lifesciences, the system optimizes operational processes, strengthens team synergy, and facilitates wider global accessibility to sophisticated cardiac interventions._x000D_
_x000D_
#Heart Defect Closure Device Market Competitive Landscape: Which Companies Lead The Industry?#_x000D_
Major companies operating in the heart defect closure device market are Abbott Laboratories, Medtronic, W L Gore and Associates, Occlutech, LifeTech Scientific Corporation, Lepu Medical Technology, Meril Life Sciences Pvt Ltd, MicroPort Scientific Corporation, Boston Scientific Corporation, Edwards Lifesciences, Terumo Corporation, Cardia Inc, Coherex Medical Inc, AtriCure Inc, Sahajanand Medical Technologies Limited, Vivasure Medical, Transmural Systems Inc, Cormatrix Cardiovascular Inc, Baylis Medical Company Inc, Biosense Webster Inc, BIOTRONIK SE and Co KG, B Braun _x000D_
_x000D_
#View The Full Heart Defect Closure Device Market Report:#_x000D_
_x000D_
#Heart Defect Closure Device Market Regional Breakdown: Where Is Demand Concentrated?#_x000D_
North America was the largest region in the heart defect closure device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the heart defect closure device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.